About OPX Biotechnologies
OPX Biotechnologies develops and produces bio-based chemicals and fuels. The OPX EDGE (Efficiency Directed Genome Engineering) technology platform enables the optimization of microbes and bioprocesses to manufacture bioproducts.
Expert Collections containing OPX Biotechnologies
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
OPX Biotechnologies is included in 1 Expert Collection, including Synthetic Biology.
Companies involved in design and development of new biological parts, devices, and systems; as well as the re-design of existing biological systems.
OPX Biotechnologies Patents
OPX Biotechnologies has filed 23 patents.
EC 2.3.1, Molecular biology, Fatty acids, Metabolism, Biotechnology
EC 2.3.1, Molecular biology, Fatty acids, Metabolism, Biotechnology
Latest OPX Biotechnologies News
Apr 20, 2017
Reprints For a cleantech startup, it can make sense to fuel growth with venture capital dollars—but only up to a certain point, said Hans Liao. That was one lesson Liao learned after he left Minnesota-based Cargill, the largest private company in the U.S., and in 2009 began working at Boulder, CO-based OPX Biotechnologies, a developer of bio-based acrylic acids and other compounds. He was one member of a panel discussion titled “Translating cleantech from bench to business and back” that was held on Tuesday in Madison, WI. The topics discussed included how early-stage companies can work with larger, more established businesses; how cleantech investment in the U.S. compares to other countries; and what effect the rise of electric vehicles might have on efforts to develop and commercialize technologies that use renewable energy sources. After Liao joined OPX Bio, the startup continued to raise money from venture capital funds, including a $36.5 million funding round in 2011 . But eventually, OPX arrived at a crossroads. One option was seeking the funding to build its own manufacturing plant, Liao said, which was likely to cost hundreds of millions of dollars. It would have also required financial backers to wait years, if not decades, before seeing a return on their investment, he added. That route didn’t have a lot of appeal to the VC firms that had funded OPX up to that point, Liao said. “We were at a point when the venture people just said, ‘We can’t put in any more money, and then have it locked up for 20 years in order to build [a plant],’” he said. So the VC groups began looking for larger organizations—ones with “infrastructure or dollars or market access,” Liao said—and encouraging them to take a closer look at OPX. In 2015, the startup was acquired by none other than Cargill, paving the way for Liao to return to his old employer. (He is currently a senior principal scientist there.) Cargill’s core business is producing and distributing food ingredients and agricultural commodities, such as starches, palm oil, and livestock feed. “In the good old days, you could get money from banks,” Liao said. But over the years, things changed, he said, in part as a result of the financial crisis that hit the U.S. in 2008. “That’s why companies like Cargill exist. We look for strategic partnerships.” Another cleantech startup acquired by a much larger business is Madison, WI-based Virent. The company develops technology aimed at producing cleaner and more sustainable liquid transportation fuels. It’s also working on plant-derived materials that could be used to make everything from plastic bottles to carpeting. Last September, the San Antonio-based petroleum refiner Tesoro (NYSE: TSO ) purchased Virent for an undisclosed sum . Edgar Steenwinkel , vice president of research and development at Virent, said that despite being part of an oil giant, his company’s work on a bio-based paraxylene—a form of the chemical that can be used in packaging containers, fabrics, and other items—isn’t likely to be abandoned entirely. “Our technology is agnostic,” he said. “We can make both [fuels and chemicals]. If you look at how the dynamics are in the industry, there are advantages of developing fuels because there’s … infrastructure around it. [But] there are also advantages with chemicals because people are motivated to buy those [end products].” Tesoro’s acquisition of Virent could be viewed as a signal that the petroleum refiner … Next Page » Single Page Currently on Page: 1 2 Jeff Buchanan is the editor of Xconomy Wisconsin. Email: firstname.lastname@example.org Follow @_jeffbuchanan
OPX Biotechnologies Frequently Asked Questions (FAQ)
When was OPX Biotechnologies founded?
OPX Biotechnologies was founded in 2007.
Where is OPX Biotechnologies's headquarters?
OPX Biotechnologies's headquarters is located at 2425 55th Street, Boulder.
What is OPX Biotechnologies's latest funding round?
OPX Biotechnologies's latest funding round is Acquired.
How much did OPX Biotechnologies raise?
OPX Biotechnologies raised a total of $64.9M.
Who are the investors of OPX Biotechnologies?
Investors of OPX Biotechnologies include Cargill, XSeed Capital, Mohr Davidow Ventures, Altira Group, Braemar Energy Ventures and 5 more.
Who are OPX Biotechnologies's competitors?
Competitors of OPX Biotechnologies include Cathay Biotech, Akron Biotechnology, Agrivida, Green Biologics, Mendel Biotechnology and 9 more.
Compare OPX Biotechnologies to Competitors
Agrivida is an agricultural biotechnology company developing energy crops designed to produce chemicals, fuels, and bioproducts from non-food cellulosic biomass. The company's approach is designed to provide an integrated solution for delivering the lowest-cost sugars that are essential for industrial bioproducts. The basis of Agrivida's integrated solution is engineering the feedstock to contain cell wall-degrading enzymes, and other valuable traits, which are activated following harvest. Agrivida plans to commercialize its platform through alliances across the bioindustrial product supply chain.
Green Biologics is an industrial biotechnology company focused on the production of renewable n-butanol and other C4 chemicals from various renewable feedstocks, including sugar (cane, molasses, beets), starch (corn) and cellulosic biomass (corn residues, sugar cane bagasse, forest materials and grasses). The company works with feedstock partners to deliver capital efficient production models, and works with downstream partners to deliver high quality, competitively priced products. Green Biologics' focus is on the global renewable chemicals and biofuels markets.
Laureate Pharma, Inc. is a full service contract manufacturing organization(CMO) providing development and cGMP manufacturing services in the company's FDA registered facilities in Princeton, New Jersey. The company is dedicated to supporting the development and commercialization of biopharmaceutical, drug and diagnostic products for pharmaceutical, diagnostic and biotech companies.The company aims to provide a range of product development and manufacturing services from cell line optimization and process design to development of full-scale cGMP protein production, purification and aseptic filling, in addition to corresponding testing, validation, analytical and regulatory support. The company's focus is on mammalian cell based monoclonal antibody and recombinant protein production for clinical and modest commercial supply.The company view the company's customers as partners and provide them with flexible solutions that reduce time to clinic and market. Focused on operational excellence, the company's highly experienced staff works with the company's customers to improve the quality of their products and processes.The company value the company's customers, stakeholders and associates. Therefore, the company measure the company's success by meeting the company's customers' needs, generating results in terms of quality, timeliness and on budget performance, as well as fostering an environment of trust, growth and diversity for the company's team.
Agrisoma Biosciences is an agricultural company that has commercialized carinata, a non-food oilseed crop designed for sustainable production of biofuels. Agrisoma sells carinata seed products under the Resonance brand name, and uses advanced crop improvement technologies to provide superior crop varieties to growers.
Oceanit creates solutions through engineering consulting in civil, coastal, and environmental engineering; information systems consulting; management consulting, including Design Thinking and scientific research.
Stine Seed is an independent seed company dedicated to serving farmer customers with support from its team of agronomists and district and regional managers.